External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home Ophthalmology AAO 2026
Roche and Genentech at

AAO 2026

October 09 - October 12
New Orleans, USA
aao.org
Add to calendar
Share feedback
Share page
-
Agenda
Medical Materials
01:00 PM
Duration 30mins New Orleans, USA
Up to 7-Year Retinal Fluid Outcomes: Portal Extension Trial of the Port Delivery Platform With Ranibizumab (PDS) in nAMD
Michael Klufas, Jeremy Wolfe, Caesar Luo, Jordan Graff, John Kitchens, Gian-Andrea Thanei, Steven Blotner, Shamika Gune, Dolores Berger Lassalle, Mel Rabena, Natasha Singh
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 30mins New Orleans, USA
Port Delivery Platform With Ranibizumab Treatment in Eyes With nAMD and High Injection Burden
Jeremy Wolfe, Robert Wirthlin, Michael Klufas, Anthony Kwan Jeffrey Moore, Steven Blotner, Brianne Chin, Andrew Gordon, Shamika Gune
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
09:40 PM
Duration 10mins New Orleans, USA
Follow-up on MEERCAT and SANDCAT Trials on Vamikibart for Uveitic Macular Edema
Rahul N Khurana, Pavesio C, Sonoda KH, Suhler E, Bakri S, Zeimessen F, Lowestein A, Wong T, Avery B, Lomax M, Harrell E, Silverman D, Steeples L
Ophthalmology | Uveitic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
09:38 PM
Duration 5mins New Orleans, USA
Vamikibart for Uveitic Macular Edema: Week 52 Efficacy and Safety Results From the Phase 3 MEERKAT and SANDCAT Trials
Acharya Nisha, Khurana R, Pavesio C, Sonoda KH, Suhler E, Bakri S, Zeimessen F, Lowestein A, Wong T, Avery B, Lomax M, Harrell E, Silverman D, Steeples L
Ophthalmology | Uveitic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
02:45 PM
Duration 12mins New Orleans, USA
Visual Acuity at Week 16 of the Phase 3 MEERKAT and SANDCAT Trials of Vamikibart in Patients With Uveitic Macular Edema
Glenn Jaffe, Rahul N. Khurana, Lyndell L. Lim, Deanna Galloway, Emma Harrell, Ivo Stoilov, Zdenka Haskova, David Silverman, Laura Steeples, Eric Suhler, Dilraj Grewal
Ophthalmology | Uveitic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Coming soon

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.